The USPTO’s May 14, 2026, precedential decision in Magnolia Medical Technologies v. Kurin warrants careful scrutiny from the congressional committees with jurisdiction over patent law.
What the Magnolia Decision Gets Wrong About Inter Partes Review
The USPTO’s May 14, 2026, precedential decision in Magnolia Medical Technologies v. Kurin warrants careful scrutiny from the congressional committees with jurisdiction over patent law.
